Greenberg Traurig Shareholder Can Cui chaired a roundtable on “Licensing, Scaling, and Commercializing Advanced Cell & Gene Therapies” attended by CGT industry leaders from Sana Biotechnology, Cartesian Therapeutics, Create Medicines and ProBio.
This Biotech Showcase will also highlight transformative developments influencing the future of therapeutics, including advances in gene therapy, CAR-T technologies, and epigenetic approaches. Participants will explore emerging platforms, partnership strategies, and key opportunities fueling the next phase of innovation in the biotech sector.